🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesAnti-thrombotic properties of GLP-1 receptor activation — looking for input Page 5

Anti-thrombotic properties of GLP-1 receptor activation — looking for input

robert_kc Sun, Jan 19, 2025 at 7:30 AM 26 replies 1,964 viewsPage 5 of 6
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Jan 19, 2025 at 2:35 PM#21

DeniseRN_TPA — that is really helpful context on Anti-thrombotic. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

12 10InsuranceTom, WendyG_ATL, SaraMom3 and 9 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Jan 19, 2025 at 2:52 PM#22

To answer Dr.SleepRoch's question specifically:

From a clinical standpoint, Anti-thrombotic properties of is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

42 19raj_cambridge, ingrid_STO, pete_nash and 39 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Jan 19, 2025 at 3:09 PM#23

Thank you NicoleRaleigh! This is incredibly helpful. Taking this to my next appointment. 🙏

44 1marcus_mpls, DeniseRN_TPA, SandraNC_45 and 41 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Jan 19, 2025 at 3:26 PM#24

Relevant to Anti-thrombotic properties of — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 219 → 119 mg/dL, hsCRP 6.0 → 1.3 mg/L. All on tirzepatide for 11 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Jan 19, 2025 at 5:26 PM
28 3Dr.PeteFamMed, claudia_zurich, nancy_portland and 25 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Jan 19, 2025 at 3:43 PM#25

Slightly tangential to Anti-thrombotic but NicoleRaleigh reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Jan 19, 2025 at 9:43 PM
30 9josh_phd_bmore, roxy_nash, tony_orlando and 27 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register